-
Forbes |
Color Genomics just announced that its genetic screening tests will now cover 30 genes. Can it change how people get tested for cancer risk?
Apr 28, 2016
-
Diagnostics World | MolecularMatch runs a free online search engine for clinical trials, with a registry that is beginning to rival clinicaltrials.gov. Now it wants to arm pathology labs with the same context-aware search engine to help interpret the results of molecular tests.
Apr 28, 2016
-
MobiHealthNews |
Australia-based ResApp is preparing to apply for FDA clearance for its smartphone-based system for diagnosing respiratory conditions, which uses a smartphone microphone as a stethoscope to monitor breathing.
Apr 25, 2016
-
Forbes |
Metropolis Healthcare, a chain of diagnostics labs across India, Sri Lanka, the Middle East and Africa, is looking to nearly triple its number of labs in the the next four years.
Apr 25, 2016
-
Diagnostics World Brief | Verinata Health, acquired by Illumina in 2013, has filed a patent infringement suit against Genoma SA in the Federal Patent Court in Switzerland. Illumina is seeking all available remedies, including damages, and injunctive relief according to the company’s statement
Apr 22, 2016
-
Diagnostics World | Using a portable diagnostics platform first developed at Sandia National Labs, Sandstone Diagnostics has filed for FDA clearance of its first direct-to-consumer product, a test for male infertility.
Apr 20, 2016
-
STAT |
New diagnostics companies already faced a harder time raising capital than startups working on therapeutics - and that was before the sector's biggest investment darling imploded.
Apr 14, 2016
-
WSJ |
Theranos founder Elizabeth Holmes and President Sunny Balwani faces possible ban after Centers for Medicare and Medicaid Services said company failed to fix problems in blood testing with Edison machines, other areas.
Apr 14, 2016
-
Medical Daily | A publication in EBioMedicine details a low-cost, smartphone-connected otoscope that can test for ear infections using automated image analysis, with similar accuracy to physicians using standard otoscopes.
Apr 11, 2016
-
Diagnostics World | Invitae—which began life in 2012 promising an “all-in-one” genetic test but has since become a piecemeal provider of gene panels—has launched a new series of pediatric tests, focusing on rare, high-impact variants.
Apr 1, 2016
-
The New York Times |
Federal regulators say the blood-testing company used poorly trained workers and mishandled blood samples.
Apr 1, 2016
-
Forbes |
There's a central dictum in engineering, in medicine, in life, at which Theranos, the controversial blood test company, has constantly failed. "In God we trust," the mid-century statistician William Edward Deming quipped. "All others bring data." Now, once again, Theranos does not have data to bring. But researchers at the Icahn School of Medicine at Mt. Sinai have done their own analysis of Theranos' tests.
Mar 30, 2016
-
Bio-IT World | The myGenome service from
Veritas Genetics, a $999 screen that includes a whole genome sequence
and reports on an expansive number of health conditions, is running up
against both the financial and regulatory limits of what genetic testing
can offer today.
Mar 28, 2016
-
Boston Business Journal |
Two months after announcing an expansion into Asia, Lexington diagnostic company Quanterix will set its sights on developing a cancer test with $46 million in Series D funding.
Mar 25, 2016
-
Scientific American |
Paper sensors could detect chemical and biological molecules easily in the field, but lack of funds and commercial partners mean many advances will languish in the lab.
Mar 25, 2016
-
Diagnostics News Brief | Newborn Screening Ontario (NSO), Tute Genomics, and UNIConnect this morning announced a project to establish the informatics infrastructure for NSO's new next-generation sequencing (NGS) testing panel. Terms and conditions of the agreement were not disclosed.
Mar 22, 2016
-
Diagnostics World | A growing number of companies are creating their own custom platforms to capture and analyze circulating tumor cells or circulating tumor DNA, as co-diagnostic tools in the treatment of cancer. Biocept of San Diego is one of the few companies with solutions for analyzing both types of cancer material in whole blood.
Mar 18, 2016
-
GenomeWeb A lawsuit filed against Quest Diagnostics subsidiary Athena Diagnostics could have far reaching repercussions for the diagnostics testing industry. If the case proceeds, a jury will have to decide whether there was sufficient evidence in the literature in 2007 for Athena Diagnostics to determine a pathogenic link between mutation and disease. The decision would set industry-changing precedent.
Mar 17, 2016
-
Wired |
Since November, more than 50 people in Wisconsin have one by one fallen ill with an obscure kind of bacteria called Elizabethkingia.
Mar 17, 2016